Location: Menlo Park, CA
CIK: 0001631134 · Show all filings
Period: Q2 2023 (← Previous) (Next →)
Filing Date: Aug 14, 2023
Total Value: $1.527B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| — | Karuna Therapeutics Inc | 1,381,149 | $300M | 19.6% | $216.85 | $32.21 | — | COM | 48576A100 |
| NTRA | Natera Inc | 3,100,560 | $151M | 9.9% | $48.66 * | $9.81 | +420.1% | COM | 632307104 |
| AZN | AstraZeneca PLC | 1,697,517 | $121M | 8.0% | $71.57 | $71.57 | — | SPONSORED ADR | 046353108 |
| ISRG | Intuitive Surgical Inc | 201,182 | $68.79M | 4.5% | $341.94 * | $260.77 | +16.0% | COM | 46120E602 |
| ASND | Ascendis Pharma A/S | 754,032 | $67.3M | 4.4% | $89.25 | $92.54 | — | SPONSORED ADR | 04351P101 |
| — | Aerovate Therapeutics Inc | 3,758,686 | $64.46M | 4.2% | $17.15 | $22.83 | — | COM | 008064107 |
| MRK | Merck & Co Inc | 527,373 | $60.85M | 4.0% | $115.39 * | $85.36 | +22.4% | COM | 58933Y105 |
| VERA | Vera Therapeutics Inc | 3,467,156 | $55.65M | 3.6% | $16.05 * | $15.35 | -41.2% | CL A | 92337R101 |
| VRTX | Vertex Pharmaceuticals Inc | 145,300 | $51.13M | 3.3% | $351.91 * | $336.94 | 0.0% | COM | 92532F100 |
| EXEL | Exelixis Inc | 2,560,738 | $48.94M | 3.2% | $19.11 | $18.67 | +3.2% | COM | 30161Q104 |
| DXCM | Dexcom Inc | 370,720 | $47.64M | 3.1% | $128.51 * | $107.27 | +12.7% | COM | 252131107 |
| IDXX | IDEXX Laboratories Inc | 70,674 | $35.49M | 2.3% | $502.23 * | $479.21 | 0.0% | COM | 45168D104 |
| IMTX | Immatics NV | 3,041,487 | $35.1M | 2.3% | $11.54 * | $9.71 | -3.9% | SHS | N44445109 |
| SNDX | Syndax Pharmaceuticals Inc | 1,582,291 | $33.12M | 2.2% | $20.93 | $21.35 | -2.5% | COM | 87164F105 |
| BSX | Boston Scientific Corp | 608,861 | $32.93M | 2.2% | $54.09 * | $52.23 | 0.0% | COM | 101137107 |
| — | Reata Pharmaceuticals Inc | 322,471 | $32.88M | 2.2% | $101.96 | $32.98 | — | CL A | 75615P103 |
| CYTK | Cytokinetics Inc | 843,228 | $27.51M | 1.8% | $32.62 * | $37.86 | -2.3% | COM | 23282W605 |
| — | Inhibrx Inc | 998,283 | $25.92M | 1.7% | $25.96 | $23.93 | — | COM | 45720L107 |
| ZNTL | Zentalis Pharmaceuticals Inc | 828,005 | $23.36M | 1.5% | $28.21 * | $23.30 | +3.0% | COM | 98943L107 |
| — | Inozyme Pharma Inc | 3,655,308 | $20.36M | 1.3% | $5.57 | $16.71 | — | COM | 45790W108 |
| GERN | Geron Corp | 5,429,155 | $17.43M | 1.1% | $3.21 * | $2.59 | +10.0% | COM | 374163103 |
| BAX | Baxter Intl Inc | 362,200 | $16.5M | 1.1% | $45.56 * | $40.77 | 0.0% | COM | 071813109 |
| IDYA | IDEAYA Biosciences Inc | 664,746 | $15.62M | 1.0% | $23.50 * | $15.40 | +33.5% | COM | 45166A102 |
| — | ImmunoGen Inc | 827,318 | $15.61M | 1.0% | $18.87 | $5.69 | — | COM | 45253H101 |
| ARGX | argenx SE | 39,921 | $15.56M | 1.0% | $389.73 | $389.73 | — | SPONSORED ADR | 04016X101 |
| — | Y-mAbs Therapeutics Inc | 2,194,278 | $14.9M | 1.0% | $6.79 | $26.75 | — | COM | 984241109 |
| RVMD | Revolution Medicines Inc | 520,377 | $13.92M | 0.9% | $26.75 * | $24.57 | -0.1% | COM | 76155X100 |
| AXSM | Axsome Therapeutics Inc | 179,242 | $12.88M | 0.8% | $71.86 * | $68.33 | +8.0% | COM | 05464T104 |
| VIR | Vir Biotechnology Inc | 488,117 | $11.97M | 0.8% | $24.53 * | $25.58 | -1.8% | COM | 92764N102 |
| PTCT | PTC Therapeutics Inc | 260,443 | $10.59M | 0.7% | $40.67 * | $45.71 | +7.0% | COM | 69366J200 |
| — | Marinus Pharmaceuticals Inc | 962,619 | $10.45M | 0.7% | $10.86 | $6.90 | — | COM | 56854Q200 |
| GRTX | Galera Therapeutics Inc | 3,083,712 | $9.621M | 0.6% | $3.12 * | $12.19 | -75.6% | COM | 36338D108 |
| REPL | Replimune Group Inc | 348,889 | $8.101M | 0.5% | $23.22 * | $19.54 | 0.0% | COM | 76029N106 |
| — | Agenus Inc | 4,909,132 | $7.855M | 0.5% | $1.60 | $1.77 | — | COM | 00847G705 |
| VIR | Vir Biotechnology Inc | 300,000 | $7.359M | 0.5% | $24.53 * | $25.58 | -1.8% | Put | 92764N102 |
| CLDX | Celldex Therapeutics Inc | 197,758 | $6.71M | 0.4% | $33.93 | $43.15 | -21.9% | COM | 15117B202 |
| DYN | Dyne Therapeutics Inc | 441,048 | $4.962M | 0.3% | $11.25 * | $11.80 | 0.0% | COM | 26818M108 |
| — | Nextcure Inc | 2,671,856 | $4.809M | 0.3% | $1.80 | $10.01 | — | COM | 65343E108 |
| — | Nucana PLC | 5,599,999 | $4.424M | 0.3% | $0.79 | $9.47 | — | SPONSORED ADR | 67022C106 |
| — | Bolt Biotherapeutics Inc | 2,754,437 | $3.526M | 0.2% | $1.28 | $32.91 | — | COM | 097702104 |
| — | Marinus Pharmaceuticals Inc | 200,000 | $2.172M | 0.1% | $10.86 | $6.90 | — | Call | 56854Q200 |
| — | Nucana PLC | 2,400,000 | $1.896M | 0.1% | $0.79 | $4.99 | — | COMMON SHARES | GB00BYWYV |
| — | FibroGen Inc | 650,000 | $1.755M | 0.1% | $2.70 | $2.70 | — | Put | 31572Q808 |
| — | FibroGen Inc | 637,567 | $1.721M | 0.1% | $2.70 | $2.70 | — | COM | 31572Q808 |
| PDSB | PDS Biotechnology Corp | 142,635 | $717K | 0.0% | $5.03 * | $8.36 | -21.7% | COM | 70465T107 |
| — | FibroGen Inc | 250,000 | $675K | 0.0% | $2.70 | $2.70 | — | Call | 31572Q808 |
| — | Fusion Pharmaceuticals Inc | 117,099 | $547K | 0.0% | $4.67 | $6.28 | — | COM | 36118A100 |
| SVRA | Savara Inc | 96,248 | $308K | 0.0% | $3.19 * | $2.35 | 0.0% | COM | 805111101 |
| — | Allakos Inc | 62,465 | $272K | 0.0% | $4.36 | $4.36 | — | COM | 01671P100 |
| — | Synlogic Inc | 574,972 | $247K | 0.0% | $0.43 | $9.38 | — | COM | 87166L100 |
| MIRM | Mirum Pharmaceuticals Inc | 9,089 | $235K | 0.0% | $25.87 * | $26.59 | 0.0% | COM | 604749101 |
| — | Spruce Biosciences Inc | 58,029 | $125K | 0.0% | $2.15 | $2.15 | — | COM | 85209E109 |